Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1201

1.

Long-Term Favorable Effects of Physical Exercise on Burdensome Symptoms in the OptiTrain Breast Cancer Randomized Controlled Trial.

Wiggenraad F, Bolam KA, Mijwel S, van der Wall E, Wengström Y, Altena R.

Integr Cancer Ther. 2020 Jan-Dec;19:1534735420905003. doi: 10.1177/1534735420905003.

2.

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.

Steenbruggen TG, Steggink LC, Seynaeve CM, van der Hoeven JJM, Hooning MJ, Jager A, Konings IR, Kroep JR, Smit WM, Tjan-Heijnen VCG, van der Wall E, Bins AD, Linn SC, Schaapveld M, Jacobse JN, van Leeuwen FE, Schröder CP, van Tinteren H, de Vries EGE, Sonke GS, Gietema JA.

JAMA Oncol. 2020 Jan 30. doi: 10.1001/jamaoncol.2019.6276. [Epub ahead of print]

PMID:
31999296
3.

Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles.

van Dooijeweert C, van der Wall E, Baas IO.

Neth J Med. 2019 Dec;77(9):310-316.

4.

Tumor Response After Neoadjuvant Magnetic Resonance Guided Single Ablative Dose Partial Breast Irradiation.

Vasmel JE, Charaghvandi RK, Houweling AC, Philippens MEP, van Asselen B, Vreuls CPH, van Diest PJ, van Leeuwen AMG, van Gorp J, Witkamp AJ, Koelemij R, Doeksen A, Sier MF, van Dalen T, van der Wall E, van Dam I, Veldhuis WB, Kirby AM, Verkooijen HM, van den Bongard HJGD.

Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):821-829. doi: 10.1016/j.ijrobp.2019.11.406. Epub 2019 Dec 5.

PMID:
31812720
5.

Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management.

Moelans CB, Patuleia SIS, van Gils CH, van der Wall E, van Diest PJ.

Int J Mol Sci. 2019 Nov 19;20(22). pii: E5814. doi: 10.3390/ijms20225814.

6.

Off to a good start after a cancer diagnosis: implementation of a time out consultation in primary care before cancer treatment decision.

Noteboom EA, de Wit NJ, van Asseldonk IJEM, Janssen MCAM, Lam-Wong WY, Linssen RHPJ, Pepels MJAE, Schrama NAWP, Trompper MEH, Veldhuizen LM, Wijtvliet AP, Zeldenrust EGF, Hendrikx AM, van de Boomen WA, Elbersen DM, Jacobs EMG, van der Wall E, Helsper CW.

J Cancer Surviv. 2020 Feb;14(1):9-13. doi: 10.1007/s11764-019-00814-5. Epub 2019 Nov 16.

7.

Doxorubicin-induced skeletal muscle atrophy: Elucidating the underlying molecular pathways.

Hiensch AE, Bolam KA, Mijwel S, Jeneson JAL, Huitema ADR, Kranenburg O, van der Wall E, Rundqvist H, Wengstrom Y, May AM.

Acta Physiol (Oxf). 2019 Oct 10:e13400. doi: 10.1111/apha.13400. [Epub ahead of print] Review.

PMID:
31600860
8.

The Use of Expectancy and Empathy When Communicating With Patients With Advanced Breast Cancer; an Observational Study of Clinician-Patient Consultations.

van Vliet LM, Francke AL, Meijers MC, Westendorp J, Hoffstädt H, Evers AWM, van der Wall E, de Jong P, Peerdeman KJ, Stouthard J, van Dulmen S.

Front Psychiatry. 2019 Jul 17;10:464. doi: 10.3389/fpsyt.2019.00464. eCollection 2019.

9.

The molecular genetic make-up of male breast cancer.

Moelans CB, de Ligt J, van der Groep P, Prins P, Besselink NJM, Hoogstraat M, Ter Hoeve ND, Lacle MM, Kornegoor R, van der Pol CC, de Leng WWJ, Barbé E, van der Vegt B, Martens J, Bult P, Smit VTHBM, Koudijs MJ, Nijman IJ, Voest EE, Selenica P, Weigelt B, Reis-Filho JS, van der Wall E, Cuppen E, van Diest PJ.

Endocr Relat Cancer. 2019 Oct;26(10):779-794. doi: 10.1530/ERC-19-0278.

PMID:
31340200
10.

Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.

Witlox L, Schagen SB, de Ruiter MB, Geerlings MI, Peeters PHM, Koevoets EW, van der Wall E, Stuiver M, Sonke G, Velthuis MJ, Palen JAMV, Jobsen JJ, May AM, Monninkhof EM.

BMJ Open. 2019 Jun 20;9(6):e028117. doi: 10.1136/bmjopen-2018-028117.

11.

The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer.

van Steenhoven JEC, Kuijer A, Schreuder K, Elias SG, van Diest PJ, van der Wall E, Siesling S, van Dalen T.

Ann Surg Oncol. 2019 Oct;26(11):3495-3501. doi: 10.1245/s10434-019-07511-8. Epub 2019 Jun 17.

12.

Involving the general practitioner during curative cancer treatment: a systematic review of health care interventions.

Perfors IAA, May AM, Boeijen JA, de Wit NJ, van der Wall E, Helsper CW.

BMJ Open. 2019 Apr 14;9(4):e026383. doi: 10.1136/bmjopen-2018-026383.

13.

Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands.

van Dooijeweert C, van Diest PJ, Willems SM, Kuijpers CCHJ, van der Wall E, Overbeek LIH, Deckers IAG.

Int J Cancer. 2020 Feb 1;146(3):769-780. doi: 10.1002/ijc.32330. Epub 2019 Apr 29.

14.

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands.

van Dooijeweert C, Deckers IAG, Baas IO, van der Wall E, van Diest PJ.

Breast Cancer Res Treat. 2019 Jun;175(2):487-497. doi: 10.1007/s10549-019-05180-5. Epub 2019 Mar 1.

15.

Tamoxifen and pregnancy: an absolute contraindication?

Schuurman TN, Witteveen PO, van der Wall E, Passier JLM, Huitema ADR, Amant F, Lok CAR.

Breast Cancer Res Treat. 2019 May;175(1):17-25. doi: 10.1007/s10549-019-05154-7. Epub 2019 Feb 1. Review.

PMID:
30707336
16.

Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis.

Vervoort SJ, de Jong OG, Roukens MG, Frederiks CL, Vermeulen JF, Lourenço AR, Bella L, Vidakovic AT, Sandoval JL, Moelans C, van Amersfoort M, Dallman MJ, Bruna A, Caldas C, Nieuwenhuis E, van der Wall E, Derksen P, van Diest P, Verhaar MC, Lam EW, Mokry M, Coffer PJ.

Elife. 2018 Dec 3;7. pii: e27706. doi: 10.7554/eLife.27706.

17.

Cardio-oncology: an overview on outpatient management and future developments.

Teske AJ, Linschoten M, Kamphuis JAM, Naaktgeboren WR, Leiner T, van der Wall E, Kuball J, van Rhenen A, Doevendans PA, Cramer MJ, Asselbergs FW.

Neth Heart J. 2018 Nov;26(11):521-532. doi: 10.1007/s12471-018-1148-7. Review.

18.

Four-year effects of exercise on fatigue and physical activity in patients with cancer.

Witlox L, Hiensch AE, Velthuis MJ, Steins Bisschop CN, Los M, Erdkamp FLG, Bloemendal HJ, Verhaar M, Ten Bokkel Huinink D, van der Wall E, Peeters PHM, May AM.

BMC Med. 2018 Jun 8;16(1):86. doi: 10.1186/s12916-018-1075-x.

19.

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer.

Moelans CB, van Maldegem CMG, van der Wall E, van Diest PJ.

Oncotarget. 2018 Mar 30;9(24):17078-17092. doi: 10.18632/oncotarget.24904. eCollection 2018 Mar 30.

20.

Response to A. Matikas et al.

Schrijver WAME, Suijkerbuijk KPM, van der Wall E, Moelans CB, van Diest PJ.

J Natl Cancer Inst. 2018 Nov 1;110(11):1282-1283. doi: 10.1093/jnci/djy048. No abstract available.

PMID:
29618030
21.

Chemotherapy-Related Cardiac Dysfunction: A Systematic Review of Genetic Variants Modulating Individual Risk.

Linschoten M, Teske AJ, Cramer MJ, van der Wall E, Asselbergs FW.

Circ Genom Precis Med. 2018 Jan;11(1):e001753. doi: 10.1161/CIRCGEN.117.001753.

PMID:
29557343
22.
23.

Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.

Schrijver WAME, Suijkerbuijk KPM, van Gils CH, van der Wall E, Moelans CB, van Diest PJ.

J Natl Cancer Inst. 2018 Jun 1;110(6):568-580. doi: 10.1093/jnci/djx273.

PMID:
29315431
24.

Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study.

Dackus GMHE, Jóźwiak K, Sonke GS, van der Wall E, van Diest PJ, Hauptmann M, Siesling S, Linn SC.

Eur J Cancer. 2018 Feb;90:92-101. doi: 10.1016/j.ejca.2017.11.010. Epub 2017 Dec 21.

25.

Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy.

van Vulpen JK, Schmidt ME, Velthuis MJ, Wiskemann J, Schneeweiss A, Vermeulen RCH, Habermann N, Ulrich CM, Peeters PHM, van der Wall E, May AM, Steindorf K.

Breast Cancer Res Treat. 2018 Apr;168(2):421-431. doi: 10.1007/s10549-017-4608-7. Epub 2017 Dec 12.

PMID:
29235043
26.

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.

Dackus GM, Ter Hoeve ND, Opdam M, Vreuls W, Varga Z, Koop E, Willems SM, Van Deurzen CH, Groen EJ, Cordoba A, Bart J, Mooyaart AL, van den Tweel JG, Zolota V, Wesseling J, Sapino A, Chmielik E, Ryska A, Amant F, Broeks A, Kerkhoven R, Stathonikos N, Veta M, Voogd A, Jozwiak K, Hauptmann M, Hoogstraat M, Schmidt MK, Sonke G, van der Wall E, Siesling S, van Diest PJ, Linn SC.

BMJ Open. 2017 Nov 14;7(11):e017842. doi: 10.1136/bmjopen-2017-017842.

27.

Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice.

de Groot JS, van Diest PJ, van Amersfoort M, Vlug EJ, Pan X, Ter Hoeve ND, Rosing H, Beijnen JH, Youssef SA, de Bruin A, Jonkers J, van der Wall E, Derksen PWB.

Oncotarget. 2017 Jun 15;8(37):60750-60763. doi: 10.18632/oncotarget.18490. eCollection 2017 Sep 22.

28.

Corrigendum: p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

van de Ven RAH, de Groot JS, Park D, van Domselaar R, de Jong D, Szuhai K, van der Wall E, Rueda OM, Ali HR, Caldas C, van Diest PJ, Hetzer MW, Sahai E, Derksen PWB.

Nat Commun. 2017 Sep 6;8:16030. doi: 10.1038/ncomms16030. eCollection 2017.

29.

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer.

Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V.

Onco Targets Ther. 2017 Jul 17;10:3501-3513. doi: 10.2147/OTT.S140639. eCollection 2017.

30.

Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol.

Charaghvandi RK, van Asselen B, Philippens ME, Verkooijen HM, van Gils CH, van Diest PJ, Pijnappel RM, Hobbelink MG, Witkamp AJ, van Dalen T, van der Wall E, van Heijst TC, Koelemij R, van Vulpen M, van den Bongard HJ.

BMC Cancer. 2017 Mar 9;17(1):181. doi: 10.1186/s12885-017-3144-5.

31.

Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study.

May AM, Bosch MJ, Velthuis MJ, van der Wall E, Steins Bisschop CN, Los M, Erdkamp F, Bloemendal HJ, de Roos MA, Verhaar M, Ten Bokkel Huinink D, Peeters PH, de Wit GA.

BMJ Open. 2017 Mar 6;7(3):e012187. doi: 10.1136/bmjopen-2016-012187.

32.

Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer.

Heerma van Voss MR, Brilliant JD, Vesuna F, Bol GM, van der Wall E, van Diest PJ, Raman V.

Med Oncol. 2017 Mar;34(3):33. doi: 10.1007/s12032-017-0889-2. Epub 2017 Jan 30.

33.

Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.

Lamberts LE, Koch M, de Jong JS, Adams ALL, Glatz J, Kranendonk MEG, Terwisscha van Scheltinga AGT, Jansen L, de Vries J, Lub-de Hooge MN, Schröder CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WPTM, Van der Wall E, van Diest PJ, de Vries EGE, Ntziachristos V, van Dam GM.

Clin Cancer Res. 2017 Jun 1;23(11):2730-2741. doi: 10.1158/1078-0432.CCR-16-0437. Epub 2016 Nov 9.

34.

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

van de Ven RA, de Groot JS, Park D, van Domselaar R, de Jong D, Szuhai K, van der Wall E, Rueda OM, Ali HR, Caldas C, van Diest PJ, Hetzer MW, Sahai E, Derksen PW.

Nat Commun. 2016 Dec 22;7:13874. doi: 10.1038/ncomms13874. Erratum in: Nat Commun. 2017 Sep 06;8:16030.

35.

The prognostic effect of DDX3 upregulation in distant breast cancer metastases.

Heerma van Voss MR, Schrijver WA, Ter Hoeve ND, Hoefnagel LD, Manson QF, van der Wall E, Raman V, van Diest PJ; Dutch Distant Breast Cancer Metastases Consortium.

Clin Exp Metastasis. 2017 Jan;34(1):85-92. doi: 10.1007/s10585-016-9832-8. Epub 2016 Dec 20.

36.

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.

Koch M, de Jong JS, Glatz J, Symvoulidis P, Lamberts LE, Adams AL, Kranendonk ME, Terwisscha van Scheltinga AG, Aichler M, Jansen L, de Vries J, Lub-de Hooge MN, Schröder CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WP, Van der Wall E, Garcia-Allende PB, van Diest PJ, de Vries EG, Walch A, van Dam GM, Ntziachristos V.

Cancer Res. 2017 Feb 1;77(3):623-631. doi: 10.1158/0008-5472.CAN-16-1773. Epub 2016 Nov 22.

37.

A Farewell to Arms.

van der Wall EE.

Neth Heart J. 2016 Dec;24(12):699-700. No abstract available.

38.

Prognostic models in male breast cancer.

van der Pol CC, Lacle MM, Witkamp AJ, Kornegoor R, Miao H, Bouchardy C, Borel Rinkes I, van der Wall E, Verkooijen HM, van Diest PJ.

Breast Cancer Res Treat. 2016 Nov;160(2):339-346. Epub 2016 Sep 26.

39.

A longer life at the top of Mount Olympus?

van der Wall EE.

Neth Heart J. 2016 Oct;24(10):561-2. doi: 10.1007/s12471-016-0894-7. No abstract available.

40.

Too little too late for young women with STEMI.

Appelman Y, van der Wall EE.

EuroIntervention. 2016 Aug 5;12(5):e536-7. doi: 10.4244/EIJV12I5A91. No abstract available.

41.

Impact factors 2015; NHJ on the rise!

van der Wall EE.

Neth Heart J. 2016 Sep;24(9):493-4. doi: 10.1007/s12471-016-0870-2. No abstract available.

42.

Cardiac disease and depression; a direct association?

van der Wall EE.

Neth Heart J. 2016 Sep;24(9):495-7. doi: 10.1007/s12471-016-0868-9. No abstract available.

43.

p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice.

Tenhagen M, Klarenbeek S, Braumuller TM, Hofmann I, van der Groep P, Ter Hoeve N, van der Wall E, Jonkers J, Derksen PW.

J Mammary Gland Biol Neoplasia. 2016 Dec;21(3-4):81-88. Epub 2016 Jul 13.

44.

Pulmonary hypertension: the importance of a multidisciplinary approach.

Post MC, van der Wall EE.

Neth Heart J. 2016 Jun;24(6):369-371. doi: 10.1007/s12471-016-0848-0. No abstract available.

45.

E-Health: a novel way to redesigning healthcare.

van der Wall EE.

Neth Heart J. 2016 Jul;24(7-8):439-40. doi: 10.1007/s12471-016-0843-5. No abstract available.

46.

Einthoven dissertation prizes 2015.

van der Wall EE.

Neth Heart J. 2016 May;24(5):355-62. doi: 10.1007/s12471-016-0835-5. No abstract available.

47.

The stethoscope: celebration or cremation after 200 years?

van der Wall EE.

Neth Heart J. 2016 May;24(5):303-5. doi: 10.1007/s12471-016-0826-6. No abstract available.

48.

NVVC/NHJ Durrer prizes 2015.

van der Wall EE.

Neth Heart J. 2016 May;24(5):306-7. doi: 10.1007/s12471-016-0827-5.

49.

DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection.

de Groot JS, Moelans CB, Elias SG, Jo Fackler M, van Domselaar R, Suijkerbuijk KP, Witkamp AJ, Sukumar S, van Diest PJ, van der Wall E.

Oncotarget. 2016 Apr 26;7(17):24778-91. doi: 10.18632/oncotarget.8352.

50.

Heart failure with preserved ejection fraction: current status and challenges for the future.

van der Velden J, van der Wall EE, Paulus WJ.

Neth Heart J. 2016 Apr;24(4):225-6. doi: 10.1007/s12471-016-0808-8. No abstract available.

Supplemental Content

Loading ...
Support Center